Refractory or Recurrent Neuroblastoma in Children
1 clinical trials · Condition
◉ Watch Refractory or Recurrent Neuroblastoma in Children
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Anlotinib, Irinotecan and Temozolomide in the Treatment of Refractory or Recurrent Neuroblastoma in Children: an Open, Single Arm, Single Center, Phase II Clinical Study (NCT04842526) | Tianjin Medical University Cancer Institute and Hospital | 2021-04-12 |
Track Refractory or Recurrent Neuroblastoma in Children automatically
Every clearance here is in the API, with alerts when new ones post.